Showing results (151-160 of 171) with videos related to
Sort By:
Pageof 18
Leukemia|June 2, 2007
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutationsA Pardanani, J Hood, T Lasho, et al.Cancer Research|April 23, 2009
Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatinTrevor Hay, James R Matthews, Lucie Pietzka, et al.Bioorganic & Medicinal Chemistry Letters|June 27, 2008
Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymeraseKeith A Menear, Claire Adcock, Francisco Cuenca Alonso, et al.Journal of Medicinal Chemistry|April 13, 2001
Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapyM B Martin, J S Grimley, J C Lewis, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 1999
Phenotypic expressions of CCR5-delta32/delta32 homozygosityG T Nguyêñ, M Carrington, J A Beeler, et al.Leukemia|October 24, 2012
Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemiaM R Janes, C Vu, S Mallya, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 7, 2018
Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish studyL Minig, S Cabrera, R Oliver, et al.Nature|April 15, 2005
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyHannah Farmer, Nuala McCabe, Christopher J Lord, et al.Journal of Medicinal Chemistry|March 23, 2011
5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2)Peter T Sunderland, Esther C Y Woon, Archana Dhami, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatinBastiaan Evers, Rinske Drost, Eva Schut, et al.Pageof 18